Van Esch A, Van Steensel-Moll H A, Steyerberg E W, Offringa M, Habbema J D, Derksen-Lubsen G
Department of Pediatrics, University Hospital, Rotterdam, The Netherlands.
Arch Pediatr Adolesc Med. 1995 Jun;149(6):632-7. doi: 10.1001/archpedi.1995.02170190042007.
To compare the antipyretic efficacy of ibuprofen syrup (5 mg/kg per dose) and acetaminophen syrup (10 mg/kg per dose) in children with a history of febrile seizures.
Randomized, multiple-dose, double-blind, cross-over trial.
The outpatient department of a university-affiliated teaching hospital.
Seventy outpatients (mean age, 2.1 years; range, 10 months to 4 years) who had visited the hospital because of a febrile seizure were randomized to treatment at a temperature of 38.5 degrees C or higher.
Study medication was given every 6 hours for 1 to 3 days. Rectal temperatures were recorded at 0, 2, 4, 6, 12, and 24 hours after the first dose.
The temperature 4 hours after the first dose, the mean temperature during treatment, and the highest temperature during treatment were evaluated. Analysis of covariance corrected for the initial temperature, age, weight, and cause of the fever.
Ibuprofen lowered the initial temperature from 39.1 degrees C to a mean temperature of 37.7 degrees C during treatment; acetaminophen lowered the initial temperature from 39.2 degrees C to 38.0 degrees C. Ibuprofen reduced fever 0.50 degree C more than did acetaminophen at 4 hours (95% confidence interval [CI], -0.98 to -0.02). The mean temperature was 0.26 degree C lower during ibuprofen treatment (95% CI, -0.59 to 0.07); the highest temperature was 0.30 degree C lower (95% CI, -0.73 to 0.13). In 22 patients, a second fever was treated with the opposite medication than the first. In the cross-over analysis, the respective differences were 0.66 degree C (95% CI, -1.29 to -0.06), 0.40 degree C (95% CI, -0.83 to 0.03), and 0.36 degree C (95% CI, -0.81 to 0.08) in favor of ibuprofen.
Ibuprofen and acetaminophen are effective antipyretic agents in children with a history of febrile seizures. Ibuprofen yielded significantly greater fever reduction than did acetaminophen 4 hours after the first dose. Research is needed on the value of antipyretic agents for the prevention of febrile seizure recurrence.
比较布洛芬糖浆(每剂5毫克/千克)和对乙酰氨基酚糖浆(每剂10毫克/千克)对有热性惊厥病史儿童的退热效果。
随机、多剂量、双盲、交叉试验。
一所大学附属医院门诊部。
70名因热性惊厥前来医院就诊的门诊患者(平均年龄2.1岁;范围10个月至4岁),在体温达到38.5摄氏度或更高时被随机分组接受治疗。
研究药物每6小时服用一次,持续1至3天。在首剂给药后0、2、4、6、12和24小时记录直肠温度。
评估首剂给药后4小时的体温、治疗期间的平均体温以及治疗期间的最高体温。采用协方差分析校正初始体温、年龄、体重和发热原因。
布洛芬在治疗期间将初始体温从39.1摄氏度降至平均体温37.7摄氏度;对乙酰氨基酚将初始体温从39.2摄氏度降至38.0摄氏度。布洛芬在4小时时退热效果比对乙酰氨基酚高0.50摄氏度(95%置信区间[CI],-0.98至-0.02)。布洛芬治疗期间平均体温低0.26摄氏度(95%CI,-0.59至0.07);最高体温低0.30摄氏度(95%CI,-0.73至0.13)。22例患者第二次发热时使用了与第一次相反的药物。在交叉分析中,布洛芬的相应差异分别为0.66摄氏度(95%CI,-1.29至-0.06)、0.40摄氏度(95%CI,-0.83至0.03)和0.36摄氏度(95%CI,-0.81至0.08)。
布洛芬和对乙酰氨基酚对有热性惊厥病史的儿童是有效的退热剂。首剂给药后4小时,布洛芬的退热效果比对乙酰氨基酚显著更好。需要研究退热剂对预防热性惊厥复发的价值。